NEW YORK (GenomeWeb News) – Waters today said that fourth-quarter revenues were essentially flat year over year as the firm missed analyst estimates on the top line but beat it on the bottom line.

For the three months ended Dec. 31, 2012 Waters posted $521.8 million in revenues compared to $521.4 million a year ago, missing the consensus Wall Street estimate of $522.2 million.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

Researchers hope to tease out the signature effects that different carcinogens leave on the genome to determine their contributions to disease, Mosaic reports.

The Wall Street Journal looks into the cost of new gene therapies.

An Imperial College London-led team reports that it was able to use a gene drive to control a population of lab mosquitos.

In PNAS this week: genomic effects of silver fox domestication, limited effect of mitochondrial mutations on aging in fruit flies, and more.

Oct
10
Sponsored by
Philips Genomics

This webinar will provide a first-hand look at how the Dana-Farber Cancer Center is adapting its oncology care strategy in light of the rapidly evolving molecular landscape.